What Is HAND?
HIV-Associated Neurocognitive Disorder — HAND — is an umbrella term for a spectrum of cognitive, behavioral, and motor impairments caused by HIV's effects on the central nervous system1. It ranges from subtle difficulties in thinking and memory that may only be detectable on formal neuropsychological testing, to significant impairment that affects daily functioning and independence.
HAND is not a new phenomenon. In the pre-treatment era, severe HIV dementia — called AIDS Dementia Complex — was a devastating and common complication of advanced HIV disease. Antiretroviral therapy dramatically reduced the incidence of severe dementia10. But it did not eliminate HAND. Milder forms of neurocognitive impairment persist in a substantial proportion of PLHIV even on effective treatment — and the reasons why are still being actively researched.
Estimates of HAND prevalence vary widely depending on the population studied and the diagnostic criteria used, but the broad consensus is that between 30 and 50 percent of PLHIV experience some degree of neurocognitive impairment — making it one of the most common complications of HIV in the treatment era2.
HAND is not about intelligence. It is about what happens when a virus — and the inflammation it causes — gains access to the brain and rewires how it processes, retrieves, and holds information. It is a medical condition, not a personal failing.
Why HAND Happens — Even With an Undetectable Viral Load
One of the most important and most confusing aspects of HAND is that it can occur — and persist — even in people with undetectable blood viral loads on effective ART6. Understanding why requires understanding how HIV interacts with the brain differently than with the rest of the body.
The CNS Reservoir — Why the Brain Is Different
The brain is protected by the blood-brain barrier — a tightly regulated interface that controls what substances can pass from the bloodstream into the central nervous system. This barrier is also a shield for HIV: many antiretroviral medications penetrate it poorly, meaning that even when viral load in the blood is undetectable, HIV can replicate at low levels within the CNS.
HIV infects microglia and macrophages — immune cells that reside in the brain — and uses them as a reservoir. These infected cells release inflammatory cytokines and neurotoxic proteins that damage neurons and disrupt neural circuits even when the virus itself is suppressed in blood3. The result is chronic neuroinflammation that continues long after viral suppression is achieved in the periphery.
This is why HAND is not fully explained by blood viral load, and why achieving undetectable status — while the most important intervention — does not guarantee cognitive preservation.
Additional factors contribute to HAND risk and severity in PLHIV. Age — the interaction between HIV-related neuroinflammation and normal brain aging — is increasingly recognized as a major factor, particularly for long-term survivors5. Cardiovascular risk factors, including hypertension, diabetes, and lipid abnormalities — all more common in PLHIV — independently affect brain health8. Depression, which is highly prevalent in PLHIV and itself impairs cognition, can both mimic and worsen HAND. And the neurotoxicity of some older antiretroviral medications has left lasting effects on long-term survivors.
The Three Stages of HAND
HAND is classified into three stages that represent a spectrum from subtle to severe. Understanding where on that spectrum a person falls matters for prognosis, treatment decisions, and practical accommodations.
What HAND Feels Like — Symptoms to Know
The symptoms of milder HAND — the forms most common in people on effective ART — are often subtle enough that they are dismissed as stress, aging, depression, or simply "brain fog." This is one of the primary reasons HAND goes undiagnosed. Knowing what to watch for — and how to describe it to your provider — is essential.
Common Symptoms of HAND in the ART Era
- Processing speed slowing: Thinking feels slower than it used to — taking longer to follow conversations, slower to respond, difficulty keeping up with fast-moving discussions
- Memory difficulties: Forgetting recent conversations, appointments, or where things were put — short-term memory more affected than long-term
- Word-finding difficulties: Losing words mid-sentence, knowing what you want to say but being unable to retrieve the word — sometimes called "tip of the tongue" phenomenon happening more frequently
- Executive function changes: Difficulty planning, organizing, multitasking, or managing complex tasks like finances, scheduling, or problem-solving
- Attention and concentration: Difficulty sustaining focus, being easily distracted, losing track in conversations or while reading
- Motor slowing: Subtle changes in coordination, handwriting, or fine motor tasks — sometimes noticed by others before the person themselves
- Behavioral and mood changes: Apathy, irritability, depression, or personality changes that seem out of character — these can be neurological rather than purely psychological
HAND vs. Depression vs. Normal Aging — Why It Matters
The symptoms of HAND, depression, and normal cognitive aging overlap significantly — and all three are more prevalent in PLHIV. Depression causes cognitive impairment that can closely mimic HAND. Normal aging slows processing speed and affects memory. Distinguishing between these requires formal neuropsychological testing, not a clinical judgment call in a brief appointment. If you are experiencing cognitive symptoms, ask for a formal evaluation rather than accepting "it's just stress" or "it's just aging" without testing.
Getting a HAND Diagnosis
HAND diagnosis requires formal neuropsychological testing — a battery of standardized tests that evaluate multiple cognitive domains including memory, processing speed, executive function, attention, language, and motor function. A single brief cognitive screening test (like the MoCA or Mini-Mental State Exam) is not sufficient to diagnose HAND — these tools were developed for Alzheimer's detection and miss the pattern of impairment characteristic of HIV-related cognitive decline.
The Diagnostic Process
- Raise it with your HIV provider: Start the conversation. Describe specific examples of what you're experiencing — not just "my memory is bad" but "I lost a word I know in the middle of a meeting" or "I've been paying the same bill twice because I can't track it." Specifics matter.
- Rule out other causes first: Your provider should check thyroid function, B12 and folate, complete metabolic panel, lipid panel, HbA1c, and screen for depression before attributing symptoms to HAND. Treatable conditions that mimic HAND must be excluded.
- Referral to neuropsychology: Formal neuropsychological testing is the standard for HAND diagnosis. Ask for a referral to a neuropsychologist — ideally one with HIV experience. Testing typically takes 2–4 hours and provides a detailed profile of cognitive strengths and weaknesses.
- Brain MRI: Neuroimaging can identify structural brain changes associated with HIV — white matter abnormalities, brain atrophy, or other findings. An MRI is often part of the workup for new cognitive symptoms in PLHIV.
- CSF analysis: In some cases — particularly when CNS viral replication is suspected — a lumbar puncture (spinal tap) to analyze cerebrospinal fluid may be warranted. CSF viral load can be detectable even when blood viral load is undetectable.
What Helps — Treatment and Management
There is no medication specifically approved for HAND. Management focuses on optimizing ART, addressing contributing factors, and cognitive rehabilitation. The good news is that several of these interventions have meaningful evidence behind them.
Evidence-Based Approaches to HAND Management
- ART optimization — CNS penetration effectiveness (CPE): Not all antiretrovirals penetrate the blood-brain barrier equally. The CPE score is a ranking system for ART drugs based on their CNS penetration4. If CNS HIV replication is suspected, switching to a regimen with higher CPE scores — in consultation with your HIV provider and ideally an HIV neurologist — may be beneficial. This is a nuanced clinical decision that requires expert guidance.
- Aggressive management of cardiovascular risk factors: Blood pressure control, cholesterol management, diabetes management, and smoking cessation all protect brain health and have evidence in slowing cognitive decline in the general population. In PLHIV, these risk factors compound HIV-related neuroinflammation — managing them is a direct intervention for brain health.
- Treatment of depression: Depression both mimics and worsens HAND. Effective depression treatment — medication, therapy, or both — can produce significant apparent improvement in cognitive symptoms, and distinguishes depression-driven cognitive impairment from HIV-driven impairment.
- Cognitive rehabilitation: Structured programs that train attention, memory, and executive function — developed in rehabilitation medicine — have shown benefit in PLHIV with HAND in several studies7. Ask your neuropsychologist about referral to cognitive rehabilitation.
- Exercise: Aerobic exercise has the strongest evidence of any lifestyle intervention for protecting and improving cognitive function — in the general population and specifically in PLHIV. Even modest increases in aerobic activity have measurable effects on brain health markers.
- Sleep treatment: Poor sleep worsens cognitive performance significantly. PLHIV have high rates of sleep disorders including insomnia and sleep apnea — both of which impair the memory consolidation and neural repair that occurs during sleep. See our HIV & Sleep article for more.
Daily Strategies — Living and Working With HAND
Cognitive compensatory strategies — techniques that work around cognitive limitations rather than through them — can dramatically improve daily functioning for people living with HAND. These are not giving up. They are the same tools that elite performers and high-functioning people use when cognitive demands exceed cognitive capacity.
Practical Compensatory Strategies
- Externalize memory: Stop relying on internal memory for things that can be written down or tracked digitally. Calendar everything. Use reminders. Keep a notebook. The goal is to reduce the cognitive load on a system that is working harder than it should have to.
- Reduce multitasking: Multitasking is a myth for most people — and it is particularly costly for people with processing speed and attention difficulties. Single-task where possible. Close browser tabs. Put the phone down during conversations.
- Structure and routine: Predictable daily routines reduce the cognitive demand of decision-making and planning. The more that can be made automatic, the more cognitive resources are available for things that actually require them.
- Communicate with your workplace: If HAND is affecting your work, reasonable accommodations under the ADA may be available — extended deadlines, written rather than verbal instructions, reduced multitasking demands. See our HIV & Disability article for more on workplace rights.
- Simplify medication regimens: If you are on a complex medication schedule, cognitive impairment makes adherence harder — and missed ART doses worsen HAND. Discuss simplification to a once-daily single-tablet regimen with your provider if adherence is being affected.
- Tell people close to you: HAND symptoms can be misinterpreted by family, friends, and colleagues as inattentiveness, rudeness, or disengagement. Explaining what is happening — to the people you trust — can reduce interpersonal friction and build support.
Florida — Finding HAND Evaluation and Support
🌴 Florida Resources for HAND
University of Miami — HIV Neurology: The University of Miami Miller School of Medicine has one of the strongest HIV neurology programs in the Southeast, with specific expertise in HAND evaluation and management. For PLHIV in South Florida experiencing cognitive symptoms, this is the most specialized resource available.
University of Florida Health — Neurology (Gainesville): UF Health's neurology program has experience with HIV-associated neurological conditions. For PLHIV in North and Central Florida, UF Health or Shands Hospital is a key referral destination for complex neurological presentations.
Ryan White neuropsychology referrals: Ask your Ryan White case manager whether neuropsychological testing is a covered service in your area. Formal HAND evaluation requires neuropsychology — a referral through Ryan White may make it accessible9.
VA Medical Centers (for veterans): Florida's VA system — including the Miami VA, Tampa VA, and Orlando VA — provides neuropsychological testing and HIV neurology services for eligible veterans living with HIV.
Memory and aging programs: Florida's academic medical centers have memory disorder programs — originally designed for Alzheimer's disease — that can also evaluate and support PLHIV with HAND. These programs often have neuropsychology, neurology, social work, and occupational therapy integrated.
Use the RiseUpToHIV Florida Locator to find HIV specialty care near you.
References & Sources
- Antinori A, et al. Updated research nosology for HIV-associated neurocognitive disorders. Neurology, 2007. neurology.org ↩
- Heaton RK, et al. HIV-associated neurocognitive disorders before and during the era of combination antiretroviral therapy: differences in rates, nature, and predictors. Journal of NeuroVirology, 2011. ↩
- Clifford DB, Ances BM. HIV-associated neurocognitive disorder. Lancet Infectious Diseases, 2013. thelancet.com ↩
- Letendre S, et al. Validation of the CNS Penetration-Effectiveness rank for quantifying antiretroviral penetration into the central nervous system. Archives of Neurology, 2008. ↩
- Valcour V, et al. Age and HIV infection predict cognitive decline in older HIV-infected persons. Neuroepidemiology, 2011. ↩
- Cysique LA, Brew BJ. Prevalence of non-confounded HIV-associated neurocognitive impairment in the context of plasma HIV RNA suppression. Journal of NeuroVirology, 2011. ↩
- Dufouil C, et al. Cognitive rehabilitation in HIV. Journal of Neurology, 2020. ↩
- Joska JA, et al. Association of HIV infection and antiretroviral therapy with the frailty phenotype. JAIDS, 2020. ↩
- HRSA. Ryan White HIV/AIDS Program — Neurological Complications. hrsa.gov ↩
- CDC. HIV and the Brain. Centers for Disease Control and Prevention. cdc.gov ↩
For the full list of organizations and studies that inform RiseUpToHIV, visit our Sources page.